Knockdown of CD146 Promotes Endothelial-to-mesenchymal Transition Via Wnt/β-catenin Pathway

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Aug 24

PMID 36001597

Authors

Zhao-Yu Zhang

Chao Zhai

Xue-Yuan Yang

Hai-Bing Li

Li-Ling Wu

Li Li

Affiliations

Soon will be listed here.

Abstract

Purpose: Cardiac fibrosis is characterized by the excessive deposition of extracellular matrix (ECM) proteins and leads to the maladaptive changes in myocardium. Endothelial cells (ECs) undergoing mesenchymal transition contributes to the occurrence and development of cardiac fibrosis. CD146 is an adhesion molecule highly expressed in ECs. The present study was performed to explore the role of CD146 in modulating endothelial to mesenchymal transition (EndMT).

Methods: C57BL/6 mice were subjected to subcutaneous implantation of osmotic minipump infused with angiotensin II (Ang Ⅱ). Adenovirus carrying CD146 short hairpin RNA (shRNA) or CD146 encoding sequence were infected into cultured human umbilical vein endothelial cells (HUVECs) followed by stimulation with Ang II or transforming growth factor-β1 (TGF-β1). Differentially expressed genes were revealed by RNA-sequencing (RNA-Seq) analysis. Gene expression was measured by quantitative real-time PCR, and protein expression and distribution were determined by Western blot and immunofluorescence staining, respectively.

Results: CD146 was predominantly expressed by ECs in normal mouse hearts. CD146 was upregulated in ECs but not fibroblasts and myocytes in hearts of Ang II-infused mice and in HUVECs stimulated with Ang Ⅱ. RNA-Seq analysis revealed the differentially expressed genes related to EndMT and Wnt/β-catenin signaling pathway. CD146 knockdown and overexpression facilitated and attenuated, respectively, EndMT induced by Ang II or TGF-β1. CD146 knockdown upregulated Wnt pathway-related genes including Wnt4, LEF1, HNF4A, FOXA1, SOX6, and CCND3, and increased the protein level and nuclear translocation of β-catenin.

Conclusions: Knockdown of CD146 exerts promotional effects on EndMT via activating Wnt/β-catenin pathway and the upregulation of CD146 might play a protective role against EndMT and cardiac fibrosis.

Citing Articles

Melanoma Cell Adhesion Molecule (CD 146) in Endometrial Physiology and Disorder.

Hilage P, Damle M, Sharma R, Joshi M Adv Exp Med Biol. 2024; 1474():131-148.

PMID: 39400880 DOI: 10.1007/5584_2024_826.

CD146, a therapeutic target involved in cell plasticity.

Wu Z, Zang Y, Li C, He Z, Liu J, Du Z Sci China Life Sci. 2024; 67(8):1563-1578.

PMID: 38613742 DOI: 10.1007/s11427-023-2521-x.

Experimental Models to Study Endothelial to Mesenchymal Transition in Myocardial Fibrosis and Cardiovascular Diseases.

Mimouni M, Lajoix A, Desmetz C Int J Mol Sci. 2024; 25(1).

PMID: 38203553 PMC: 10779210. DOI: 10.3390/ijms25010382.

Endothelial-to-Mesenchymal Transition: Potential Target of Doxorubicin-Induced Cardiotoxicity.

Feng J, Wu Y Am J Cardiovasc Drugs. 2023; 23(3):231-246.

PMID: 36841924 DOI: 10.1007/s40256-023-00573-w.

References

Porter K, Turner N . Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009; 123(2):255-78. DOI: 10.1016/j.pharmthera.2009.05.002. View

Bardin N, Moal V, Anfosso F, Daniel L, Brunet P, Sampol J . Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration. Thromb Haemost. 2003; 90(5):915-20. DOI: 10.1160/TH02-11-0285. View

Karasek M . Does transformation of microvascular endothelial cells into myofibroblasts play a key role in the etiology and pathology of fibrotic disease?. Med Hypotheses. 2006; 68(3):650-5. DOI: 10.1016/j.mehy.2006.07.053. View

Wang H, Chen H, Ma M, Wang J, Tang T, Ni L . miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule. Oncol Rep. 2013; 30(1):520-6. DOI: 10.3892/or.2013.2451. View

Williams B . Angiotensin II and the pathophysiology of cardiovascular remodeling. Am J Cardiol. 2001; 87(8A):10C-17C. DOI: 10.1016/s0002-9149(01)01507-7. View

Lehmann J, Holzmann B, Breitbart E, Schmiegelow P, Riethmuller G, Johnson J . Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res. 1987; 47(3):841-5. View

Jouve N, Bachelier R, Despoix N, Blin M, Matinzadeh M, Poitevin S . CD146 mediates VEGF-induced melanoma cell extravasation through FAK activation. Int J Cancer. 2014; 137(1):50-60. DOI: 10.1002/ijc.29370. View

Wang Z, Xu Q, Zhang N, Du X, Xu G, Yan X . CD146, from a melanoma cell adhesion molecule to a signaling receptor. Signal Transduct Target Ther. 2020; 5(1):148. PMC: 7421905. DOI: 10.1038/s41392-020-00259-8. View

Lee Y, Kim K, McKeon F, Yang A, Boyd T, Crum C . A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression. Hum Pathol. 2007; 38(7):1003-1013. DOI: 10.1016/j.humpath.2006.12.012. View

10.

Burgy O, Konigshoff M . The WNT signaling pathways in wound healing and fibrosis. Matrix Biol. 2018; 68-69:67-80. DOI: 10.1016/j.matbio.2018.03.017. View

11.

Kratzer A, Chu H, Salys J, Moumen Z, Leberl M, Bowler R . Endothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPD. J Pathol. 2013; 230(4):388-98. DOI: 10.1002/path.4197. View

12.

Dagur P, Biancotto A, Wei L, Sen H, Yao M, Strober W . MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases. J Autoimmun. 2011; 37(4):319-27. PMC: 3223259. DOI: 10.1016/j.jaut.2011.09.003. View

13.

Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M . Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol. 2008; 36(8):1035-46. DOI: 10.1016/j.exphem.2008.03.004. View

14.

Abed A, Leroyer A, Kavvadas P, Authier F, Bachelier R, Foucault-Bertaud A . Endothelial-Specific Deletion of CD146 Protects Against Experimental Glomerulonephritis in Mice. Hypertension. 2021; 77(4):1260-1272. DOI: 10.1161/HYPERTENSIONAHA.119.14176. View

15.

Gayat E, Caillard A, Laribi S, Mueller C, Sadoune M, Seronde M . Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure. Int J Cardiol. 2015; 199:241-7. DOI: 10.1016/j.ijcard.2015.07.039. View

16.

Ye Z, Zhang C, Tu T, Sun M, Liu D, Lu D . Wnt5a uses CD146 as a receptor to regulate cell motility and convergent extension. Nat Commun. 2013; 4:2803. DOI: 10.1038/ncomms3803. View

17.

Arrigo M, Truong Q, Onat D, Szymonifka J, Gayat E, Tolppanen H . Soluble CD146 Is a Novel Marker of Systemic Congestion in Heart Failure Patients: An Experimental Mechanistic and Transcardiac Clinical Study. Clin Chem. 2017; 63(1):386-393. DOI: 10.1373/clinchem.2016.260471. View

18.

Tsuchiya S, Tsukamoto Y, Taira E, LaMarre J . Involvement of transforming growth factor-beta in the expression of gicerin, a cell adhesion molecule, in the regeneration of hepatocytes. Int J Mol Med. 2007; 19(3):381-6. View

19.

Simon G, Martin R, Smith S, Thaikoottathil J, Bowler R, Barenkamp S . Up-regulation of MUC18 in airway epithelial cells by IL-13: implications in bacterial adherence. Am J Respir Cell Mol Biol. 2011; 44(5):606-13. PMC: 3095981. DOI: 10.1165/rcmb.2010-0384OC. View

20.

Bardin N, Anfosso F, Masse J, Cramer E, Sabatier F, Le Bivic A . Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood. 2001; 98(13):3677-84. DOI: 10.1182/blood.v98.13.3677. View